Governance Classic Home
Laurus Labs LtdPharmaceuticalsINE947Q01028Consolidated₹2323.80+0.80 (+0.03%)
Valuation
Market Cap₹1.25L Cr
TTM PE93.63x
Forward PE86.49x
PEG4.16
Book Value₹112.26
P/B20.70x
TTM EPS₹24.82
Fwd EPS₹26.87
TTM Revenue₹7.82K Cr
TTM PAT₹1.33K Cr
TTM EBITDA₹2.38K Cr
TTM EBIT₹1.89K Cr
Last Qtr PAT₹436.19 Cr
Last Qtr EBITDA₹750.30 Cr
Last Qtr EBIT₹622.91 Cr
Profitability
ROE21.98%
ROCE22.18%
TTM NPM17.03%
TTM EBITDA %30.44%
Curr OPM19.65%
Last OPM17.79%
Curr NPM—
Last NPM—
Curr EPS₹8.17
Last EPS₹6.81
Balance sheet
Equity₹108.06 Cr
Reserve₹5.95K Cr
Total Debt₹2,625.13 Cr
D/E0.43x
Interest %10.11%
Curr Interest₹44.10 Cr
Price / range
Close₹2323.80
vs 52W High—
vs 52W Low—
MA50—
MA200—
Returns
1D+0.03%
1W+6.50%
1M+17.13%
3M+25.61%
6M+99.23%
1Y+136.39%
2Y+376.68%
3Y+538.58%
5Y+366.16%
Diwali+109.33%
Sector peers — Pharmaceuticals
CompanyCloseMkt CapTTM P/EROE
SUNPHARMA1773.40₹4.25L Cr38.8112.31%
DIVISLAB10037.50₹2.66L Cr91.0817.45%
TORNTPHARM4738.50₹1.60L Cr77.7711.42%
LAURUSLABS2323.80₹1.25L Cr93.6321.98%
ZYDUSLIFE1188.10₹1.20L Cr28.5315.79%
DRREDDY1374.00₹1.15L Cr40.897.11%
CIPLA1402.00₹1.13L Cr39.098.06%
MANKIND2537.90₹1.05L Cr46.7112.87%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Standalone

16 lines · 6 periods
MetricSep-26Jun-26Mar-26Dec-25Sep-25FY25-26
Revenue2,014.11+28.6%1,757.161,580.301,509.421,566.606,089.07
Other Income24.7220.0713.0914.3728.4577.43
Total Income2,038.83+27.8%1,777.231,593.391,523.791,595.056,166.50
Interest38.0235.2033.9131.4833.68142.96
Expenditure-1,519.21-16.3%-1,389.06-1,334.02-1,289.35-1,306.21-5,172.41
PBDT000000
EBITDA630.61+61.8%499.06375.36345.86389.661,438.26
Depreciation-97.69-95.76-95.17-94.31-95.59-378.64
EBIT532.92+81.2%403.30280.19251.55294.071,059.62
PBT519.62+79.9%388.17259.37234.44288.84994.09
Tax-131.49-98.21-67.58-59.36-73.17-253.61
Equity108.06108.05107.97107.970107.97
OPM25.4921.8416.2815.3918.4416.12
Net Profit388.13+80.0%289.96191.79175.08215.67740.48
NPM19.0416.3212.0411.4913.7712.01
EPS7.18+79.9%5.373.553.253.9913.72

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue6,089.07+16.7%5,216.98+8.4%4,812.39-16.6%5,773.45+22.7%4,707.04-1.3%4,768.72
Other Income77.43100.4747.4215.9521.5527.32
Total Income6,166.50+16.0%5,317.45+9.4%4,859.81-16.1%5,789.40+22.4%4,728.59-1.4%4,796.04
Expenditure-5,172.41-7.5%-4,813.64-5.6%-4,558.34+3.8%-4,737.97-26.2%-3,753.18-6.6%-3,521.41
Interest-142.96-182.20-150.82-145.70-95.86-65.92
PBDT000000
EBITDA1,438.26+52.3%944.33+25.9%749.88-49.4%1,481.76+15.3%1,285.20-14.9%1,509.87
Depreciation-378.64-358.79-345.01-300.58-235.48-196.64
EBIT1,059.62+81.0%585.54+44.6%404.87-65.7%1,181.18+12.5%1,049.72-20.1%1,313.23
PBT994.09+97.3%503.81+67.1%301.47-71.3%1,051.43+7.8%975.41-23.5%1,274.63
Tax-253.61-123.42-77.77-291.05-225.32-318.52
Equity107.97107.850000
OPM (%)16.129.476.0018.0021.0027.00
Net Profit740.48+94.7%380.39+70.0%223.70-70.6%760.38+1.4%750.09-21.5%956.11
NPM (%)12.017.155.0013.0016.0020.00
EPS (Rs)13.72+94.3%7.06+70.1%4.15-70.7%14.14+1.2%13.97-21.7%17.85
CEPS13.707.054.1514.0913.9117.77

Consolidated

16 lines · 6 periods
MetricSep-26Jun-26Mar-26Dec-25Sep-25FY25-26
Revenue2,206.37+33.4%2,026.311,811.571,778.291,653.476,812.90
Other Income13.019.1811.805.7626.9654.95
Total Income2,219.38+32.1%2,035.491,823.371,784.051,680.436,867.85
Interest44.1042.2240.4438.7940170.73
Expenditure-1,627.56-15.4%-1,554.13-1,462-1,457.49-1,410.70-5,685.97
PBDT000000
EBITDA750.30+86.1%638.27512.11480.21403.261,777.71
Depreciation-127.39-123.87-122.10-120.62-120.49-480.05
EBIT622.91+120.3%514.40390.01359.59282.771,297.66
PBT591.82+119.4%481.36361.37326.56269.731,181.88
Tax-155.08-119.37-79.46-73.45-75.98-292.03
Equity108.06108.05107.9700107.97
OPM26.6723.6519.8218.3016.0517.21
Net Profit436.19+124.3%362.07282.09251.88194.49890.14
NPM19.6517.7915.4714.1211.5712.96
EPS8.17+126.3%6.815.174.673.6116.47

Yearly results

Last 6 financial years · YoY % vs previous FY

Yearly

17 lines · 6 years
MetricFY 25-26FY 24-25FY 23-24FY 22-23FY 21-22FY 20-21
Revenue6,812.90+22.7%5,553.96+10.2%5,040.83-16.6%6,040.55+22.4%4,935.57+2.5%4,813.51
Other Income54.9575.1026.34615.3023.66
Total Income6,867.85+22.0%5,629.06+11.1%5,067.17-16.2%6,046.55+22.1%4,950.87+2.4%4,837.17
Expenditure-5,685.97-10.5%-5,144.77-6.5%-4,830.81+2.2%-4,937.61-27.7%-3,867.02-9.4%-3,536.06
Interest-170.73-216-182.90-165.17-102.39-68.16
PBDT000000
EBITDA1,777.71+68.5%1,055.28+35.7%777.50-51.2%1,592.19+11.9%1,422.43-8.3%1,550.68
Depreciation-480.05-430.09-384.58-324.08-251.49-205.07
EBIT1,297.66+107.6%625.19+59.1%392.92-69.0%1,268.11+8.3%1,170.94-13.0%1,345.61
PBT1,181.88+144.0%484.29+104.9%236.36-78.7%1,108.94+2.3%1,083.85-16.7%1,301.11
Tax-292.03-129.88-68.15-312.30-251.42-317.29
Equity107.97107.850000
OPM (%)17.218.604.6618.3421.8926.90
Net Profit890.14+148.4%358.34+120.8%162.27-79.5%793.43-4.7%832.23-15.4%983.82
NPM (%)12.966.373.2013.1216.8120.34
EPS (Rs)16.47+147.7%6.65+123.2%2.98-79.7%14.69-4.7%15.42-16.0%18.36
CEPS16.456.642.9714.6415.3518.28

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

19
YearTypeAmountEx-Date
2027Interim Dividend106 Nov 2026
2027Interim Dividend1.208 May 2026
2026Interim Dividend0.831 Oct 2025
2026Interim Dividend0.809 May 2025
2025Interim Dividend0.406 Nov 2024
2025Interim Dividend0.408 May 2024
2024Interim Dividend0.402 Nov 2023
2024Interim Dividend1.210 May 2023
2023Interim Dividend0.803 Nov 2022
2023Interim Dividend1.210 May 2022
2022Interim Dividend0.817 Nov 2021
2022Interim Dividend0.811 May 2021
2021Interim Dividend0.408 Feb 2021
2021Interim Dividend0.810 Nov 2020
2020Final Dividend101 Jul 2020
2020Interim Dividend1.523 Mar 2020
2019Final Dividend1.503 Jul 2019
2018Final Dividend1.528 Jun 2018
2017Final Dividend1.506 Jul 2017

Bonus

0

No bonus history.

Split

1
YearRatioEx-Date
2020Rs.10/- to Rs.2/-29 Sep 2020
Loading company dashboard...
Fetching ratios, charts, and peers